Cargando…

The Gene Expression of Proteins Involved in Intercellular Signaling and Neurodegeneration in the Substantia Nigra in a Mouse Subchronic Model of Parkinson’s Disease

Given the limited access to clinical material for studying the pathogenesis of Parkinson’s disease (PD), these studies should be carried out on experimental models. We have recently developed a subchronic model of the progressive development of PD with a gradual transition from the preclinical (asym...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kolacheva, Anna, Pavlova, Ekaterina, Bannikova, Alyona, Bogdanov, Vsevolod, Troshev, Dmitry, Ugrumov, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9917821/ https://www.ncbi.nlm.nih.gov/pubmed/36769355 http://dx.doi.org/10.3390/ijms24033027

Ejemplares similares

Modeling of the Progressive Degradation of the Nigrostriatal Dopaminergic System in Mice to Study the Mechanisms of Neurodegeneration and Neuroplasticity in Parkinson’s Disease
por: Kolacheva, Anna, et al.
Publicado: (2022)

Compensatory Processes in Striatal Neurons Expressing the Tyrosine Hydroxylase Gene in Transgenic Mice in a Model of Parkinson’s Disease
por: Troshev, Dmitry, et al.
Publicado: (2023)

Changes in Tyrosine Hydroxylase Activity and Dopamine Synthesis in the Nigrostriatal System of Mice in an Acute Model of Parkinson’s Disease as a Manifestation of Neurodegeneration and Neuroplasticity
por: Kolacheva, Anna, et al.
Publicado: (2022)

Isolation of living dopaminergic neurons labeled with a fluorescent ligand of the dopamine transporter from mouse substantia nigra as a new tool for basic and applied research
por: Troshev, Dmitry, et al.
Publicado: (2022)

Striatal Neurons Partially Expressing a Dopaminergic Phenotype: Functional Significance and Regulation
por: Troshev, Dmitry, et al.
Publicado: (2022)

Cell–Cell Communication Alterations via Intercellular Signaling Pathways in Substantia Nigra of Parkinson’s Disease
por: Huang, Maoxin, et al.
Publicado: (2022)

Dopaminergic neurodegeneration in the substantia nigra is associated with olfactory dysfunction in mice models of Parkinson’s disease
por: Yuan, Yu, et al.
Publicado: (2023)

Dopaminergic Neurodegeneration in the Mouse Is Associated with Decrease of Viscoelasticity of Substantia Nigra Tissue
por: Hain, Elisabeth G., et al.
Publicado: (2016)

Substantia Nigra Hyperechogenicity Reflects the Progression of Dopaminergic Neurodegeneration in 6-OHDA Rat Model of Parkinson’s Disease
por: Zhang, Siyan, et al.
Publicado: (2020)

Isolated substantia nigra involvement in brainstem demyelination
por: Mahale, Rohan R., et al.
Publicado: (2015)

Proteome analysis of human substantia nigra in Parkinson's disease
por: Werner, Cornelius J, et al.
Publicado: (2008)

Glucocerebrosidase Deficiency in Substantia Nigra of Parkinson Disease Brains
por: Gegg, Matthew E, et al.
Publicado: (2012)

Proliferation of Inhibitory Input to the Substantia Nigra in Experimental Parkinsonism
por: Faynveitz, Anna, et al.
Publicado: (2019)

Soemmerring and the Substantia Nigra
por: Faull, R. L. M, et al.
Publicado: (1968)

The Periventricular Nucleus as a Brain Center Containing Dopaminergic Neurons and Neurons Expressing Individual Enzymes of Dopamine Synthesis
por: Ugrumov, Michael V., et al.
Publicado: (2022)

Altered expression of genes involved in ganglioside biosynthesis in substantia nigra neurons in Parkinson’s disease
por: Schneider, Jay S.
Publicado: (2018)

Epstein-Barr virus encephalitis with substantia nigra involvement
por: Çelik, Tamer, et al.
Publicado: (2015)

Complement activation in the Parkinson's disease substantia nigra: an immunocytochemical study
por: Loeffler, David A, et al.
Publicado: (2006)

Defective mitochondrial DNA homeostasis in the substantia nigra in Parkinson disease
por: Dölle, Christian, et al.
Publicado: (2016)

Sex-Related Abnormalities in Substantia Nigra Lipids in Parkinson’s Disease
por: Seyfried, T. N., et al.
Publicado: (2018)

Oxidative stress in the aging substantia nigra and the etiology of Parkinson's disease
por: Trist, Benjamin G., et al.
Publicado: (2019)

Complementary Transcriptomic and Proteomic Analysis in the Substantia Nigra of Parkinson's Disease
por: Dong, Bao-hua, et al.
Publicado: (2021)

Imaging of Substantia Nigra in Parkinson’s Disease: A Narrative Review
por: Feraco, Paola, et al.
Publicado: (2021)

Ferroptosis-related factors in the substantia nigra are associated with Parkinson’s disease
por: Liu, Lei, et al.
Publicado: (2023)

Classification of Parkinson’s Disease in Patch-Based MRI of Substantia Nigra
por: Hussain, Sayyed Shahid, et al.
Publicado: (2023)

Genetic Dissection of Strain Dependent Paraquat-induced Neurodegeneration in the Substantia Nigra Pars Compacta
por: Jiao, Yun, et al.
Publicado: (2012)

Somatostatin prevents lipopolysaccharide-induced neurodegeneration in the rat substantia nigra by inhibiting the activation of microglia
por: BAI, LIJUAN, et al.
Publicado: (2015)

p62 Pathology Model in the Rat Substantia Nigra with Filamentous Inclusions and Progressive Neurodegeneration
por: Jackson, Kasey L., et al.
Publicado: (2017)

Eyes as Gateways for Environmental Light to the Substantia Nigra: Relevance in Parkinson's Disease
por: Romeo, Stefania, et al.
Publicado: (2014)

Transferrin protects against Parkinsonian neurotoxicity and is deficient in Parkinson’s substantia nigra
por: Ayton, Scott, et al.
Publicado: (2016)

Mitochondrial dysfunction within the synapses of substantia nigra neurons in Parkinson’s disease
por: Reeve, Amy K., et al.
Publicado: (2018)

Corrigendum to: Spatiotemporal changes in substantia nigra neuromelanin content in Parkinson’s disease
Publicado: (2020)

Substantia Nigra Integrity Correlates with Sequential Working Memory in Parkinson's Disease
por: Liu, Wenyue, et al.
Publicado: (2021)

Reciprocal regulation between sirtuin-1 and angiotensin-II in the substantia nigra: implications for aging and neurodegeneration
por: Diaz-Ruiz, Carmen, et al.
Publicado: (2015)

A Pilot Study of Changes in the Level of Catecholamines and the Activity of α-2-Macroglobulin in the Tear Fluid of Patients with Parkinson’s Disease and Parkinsonian Mice
por: Bogdanov, Vsevolod, et al.
Publicado: (2021)

The role of substantia nigra sonography in the differentiation of Parkinson’s disease and multiple system atrophy
por: Zhou, Hai-Yan, et al.
Publicado: (2018)

Explorative Combined Lipid and Transcriptomic Profiling of Substantia Nigra and Putamen in Parkinson’s Disease
por: Xicoy, Helena, et al.
Publicado: (2020)

Irisin protects the substantia nigra dopaminergic neurons in the rat model of Parkinson’s disease
por: Zarbakhsh, Sam, et al.
Publicado: (2019)

Proteomic change by Korean Red Ginseng in the substantia nigra of a Parkinson's disease mouse model
por: Kim, Dongsoo, et al.
Publicado: (2018)

Influence of energy deficiency on the subcellular processes of Substantia Nigra Pars Compacta cell for understanding Parkinsonian neurodegeneration
por: Muddapu, Vignayanandam Ravindernath, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ql01jtsbl1rrcm05f540h9hrhh